High expression of FOXM1 in breast cancer is associated with larger tumor size, lymphovascular invasion, lymph node metastasis, aggressive phenotype, resistance to chemotherapy, and an overall poor prognosis (Saba et al., 2016; Vishnubalaji and Alajez, 2021). Here, FOXM1 is linked to neoplasm.